Vanguard Group’s Zevra Therapeutics ZVRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26M | Buy |
2,952,686
+126,841
| +4% | +$1.12M | ﹤0.01% | 2441 |
|
|
2025
Q1 | $21.2M | Buy |
2,825,845
+1,633
| +0.1% | +$12.2K | ﹤0.01% | 2482 |
|
|
2024
Q4 | $23.6M | Buy |
2,824,212
+68,151
| +2% | +$568K | ﹤0.01% | 2513 |
|
|
2024
Q3 | $19.1M | Buy |
2,756,061
+922,646
| +50% | +$6.4M | ﹤0.01% | 2607 |
|
|
2024
Q2 | $8.98M | Buy |
1,833,415
+129,409
| +8% | +$634K | ﹤0.01% | 2990 |
|
|
2024
Q1 | $9.88M | Buy |
1,704,006
+58,866
| +4% | +$341K | ﹤0.01% | 2968 |
|
|
2023
Q4 | $10.8M | Buy |
1,645,140
+32,639
| +2% | +$214K | ﹤0.01% | 2905 |
|
|
2023
Q3 | $7.77M | Buy |
1,612,501
+3,154
| +0.2% | +$15.2K | ﹤0.01% | 3034 |
|
|
2023
Q2 | $8.21M | Buy |
1,609,347
+136,554
| +9% | +$696K | ﹤0.01% | 3061 |
|
|
2023
Q1 | $8.1M | Buy |
1,472,793
+70,600
| +5% | +$388K | ﹤0.01% | 3056 |
|
|
2022
Q4 | $6.44M | Buy |
1,402,193
+21,555
| +2% | +$98.9K | ﹤0.01% | 3174 |
|
|
2022
Q3 | $8.62M | Hold |
1,380,638
| – | – | ﹤0.01% | 3025 |
|
|
2022
Q2 | $6.16M | Sell |
1,380,638
-136,274
| -9% | -$608K | ﹤0.01% | 3264 |
|
|
2022
Q1 | $7.63M | Buy |
1,516,912
+33,367
| +2% | +$168K | ﹤0.01% | 3295 |
|
|
2021
Q4 | $12.9M | Sell |
1,483,545
-109,323
| -7% | -$952K | ﹤0.01% | 3084 |
|
|
2021
Q3 | $14.9M | Buy |
1,592,868
+383,821
| +32% | +$3.58M | ﹤0.01% | 3020 |
|
|
2021
Q2 | $15.5M | Buy |
1,209,047
+391,242
| +48% | +$5.02M | ﹤0.01% | 2972 |
|
|
2021
Q1 | $7.52M | Buy |
+817,805
| New | +$7.52M | ﹤0.01% | 3316 |
|
|
2020
Q2 | – | Sell |
-1,537,991
| Closed | -$346K | – | 4099 |
|
|
2020
Q1 | $346K | Sell |
1,537,991
-16,155
| -1% | -$3.63K | ﹤0.01% | 3748 |
|
|
2019
Q4 | $589K | Sell |
1,554,146
-2,900
| -0.2% | -$1.1K | ﹤0.01% | 3765 |
|
|
2019
Q3 | $1.07M | Buy |
1,557,046
+219,475
| +16% | +$151K | ﹤0.01% | 3634 |
|
|
2019
Q2 | $2.34M | Buy |
1,337,571
+767,100
| +134% | +$1.34M | ﹤0.01% | 3428 |
|
|
2019
Q1 | $953K | Buy |
570,471
+1,800
| +0.3% | +$3.01K | ﹤0.01% | 3636 |
|
|
2018
Q4 | $1.01M | Buy |
568,671
+89,336
| +19% | +$159K | ﹤0.01% | 3561 |
|
|
2018
Q3 | $2.3M | Buy |
479,335
+40,700
| +9% | +$195K | ﹤0.01% | 3479 |
|
|
2018
Q2 | $2.85M | Buy |
438,635
+26,408
| +6% | +$172K | ﹤0.01% | 3394 |
|
|
2018
Q1 | $3.26M | Buy |
412,227
+123,242
| +43% | +$974K | ﹤0.01% | 3300 |
|
|
2017
Q4 | $1.17M | Buy |
288,985
+38,681
| +15% | +$157K | ﹤0.01% | 3571 |
|
|
2017
Q3 | $926K | Buy |
250,304
+1,187
| +0.5% | +$4.39K | ﹤0.01% | 3610 |
|
|
2017
Q2 | $997K | Sell |
249,117
-50,993
| -17% | -$204K | ﹤0.01% | 3568 |
|
|
2017
Q1 | $1.47M | Buy |
300,110
+422
| +0.1% | +$2.07K | ﹤0.01% | 3472 |
|
|
2016
Q4 | $885K | Sell |
299,688
-23,252
| -7% | -$68.7K | ﹤0.01% | 3597 |
|
|
2016
Q3 | $1.45M | Buy |
322,940
+4,730
| +1% | +$21.2K | ﹤0.01% | 3482 |
|
|
2016
Q2 | $1.27M | Buy |
318,210
+10,390
| +3% | +$41.4K | ﹤0.01% | 3536 |
|
|
2016
Q1 | $4.46M | Buy |
307,820
+26,860
| +10% | +$389K | ﹤0.01% | 3019 |
|
|
2015
Q4 | $5.58M | Buy |
280,960
+15,273
| +6% | +$303K | ﹤0.01% | 2940 |
|
|
2015
Q3 | $5.15M | Buy |
265,687
+206,844
| +352% | +$4.01M | ﹤0.01% | 2955 |
|
|
2015
Q2 | $1.08M | Buy |
+58,843
| New | +$1.08M | ﹤0.01% | 3639 |
|